Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples